Effect of Surgery on Pancreatic Tumor-Dependent Lymphocyte Asset-Reference-Cited by-同舟云学术

Effect of Surgery on Pancreatic Tumor-Dependent Lymphocyte Asset

Published:2015-04 Issue:3 Volume:44 Page:386-393
ISSN:0885-3177
Container-title:Pancreas
language:en
Short-container-title:

Author:

Iannone Francesco,Porzia Alessandra,Peruzzi Giovanna,Birarelli Patrizia,Milana Bernardina,Sacco Luca,Dinatale Giuseppe,Peparini Nadia,Prezioso Giampaolo,Battella Simone,Caronna Roberto,Morrone Stefania,Palmieri Gabriella,Mainiero Fabrizio,Chirletti Piero

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Endocrinology,Hepatology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference43 articles.

1. Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up.;Seufferlein;Ann Oncol,2012

2. Surgical treatment of pancreatic cancer.;Loos;Ann N Y Acad Sci,2008

3. Survival of patients with periampullary carcinoma is predicted by lymph node 8a but not by lymph node 16b1 status.;Connor;Br J Surg,2004

4. The ratio of metastaticresected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer.;Sierzega;Pancreas,2006

5. The metastaticexamined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma.;Berger;Am Surg,2004

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of surgical trauma and intraoperative blood loss on tumour progression;Frontiers in Oncology;2024-06-07

2. Perioperative factors associated with survival following surgery for pancreatic cancer – a nationwide analysis of 473 cases from Denmark.;BMC Surgery;2024-03-02

3. An Fc-modified monoclonal antibody as novel treatment option for pancreatic cancer;Frontiers in Immunology;2024-01-22

4. Origin, Metastasis, Harm, Recognition and Capture, and Elimination of Circulating Tumor Cells;Advanced Materials Technologies;2024-01-17

5. Ovarian cancer treatment and natural killer cell-based immunotherapy;Frontiers in Immunology;2023-12-21